Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1

Peragill is an initiative that ultimately aims to develop an alternative treatment for the currently available therapies for amoebic gill disease (AGD) that have several practical and environmental issues. Peracetic acid (PAA) is a potent oxidant with a broad spectrum of antimicrobial activity and d...

Full description

Bibliographic Details
Main Authors: Lazado, Carlo Cabacang, Timmerhaus, Gerrit, Pedersen, Lars-Flemming, Pittman, Karin, Soleng, Malene, Haddeland, Sindre, Johansen, Lill-Heidi, Breiland, Mette W, Rørmark, Lisbeth, Mohammed, Saima Nasrin, Hytterød, Sigurd
Format: Book
Language:English
Published: Nofima 2019
Subjects:
Paa
Online Access:https://orbit.dtu.dk/en/publications/8c45ca07-96de-429a-9444-eaedb48feba3
https://backend.orbit.dtu.dk/ws/files/201066543/untitled.pdf
id ftdtupubl:oai:pure.atira.dk:publications/8c45ca07-96de-429a-9444-eaedb48feba3
record_format openpolar
spelling ftdtupubl:oai:pure.atira.dk:publications/8c45ca07-96de-429a-9444-eaedb48feba3 2023-05-15T15:33:02+02:00 Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1 Lazado, Carlo Cabacang Timmerhaus, Gerrit Pedersen, Lars-Flemming Pittman, Karin Soleng, Malene Haddeland, Sindre Johansen, Lill-Heidi Breiland, Mette W Rørmark, Lisbeth Mohammed, Saima Nasrin Hytterød, Sigurd 2019 application/pdf https://orbit.dtu.dk/en/publications/8c45ca07-96de-429a-9444-eaedb48feba3 https://backend.orbit.dtu.dk/ws/files/201066543/untitled.pdf eng eng Nofima info:eu-repo/semantics/openAccess Lazado , C C , Timmerhaus , G , Pedersen , L-F , Pittman , K , Soleng , M , Haddeland , S , Johansen , L-H , Breiland , M W , Rørmark , L , Mohammed , S N & Hytterød , S 2019 , Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1 . Nofima Marked. Rapport , no. 21/2019 , Nofima . Amoebic gill disease Disinfectant Gill health Hydrogen peroxide Mucosal health Peracetic acid book 2019 ftdtupubl 2022-08-14T08:36:34Z Peragill is an initiative that ultimately aims to develop an alternative treatment for the currently available therapies for amoebic gill disease (AGD) that have several practical and environmental issues. Peracetic acid (PAA) is a potent oxidant with a broad spectrum of antimicrobial activity and decays into relatively safe residuals, thus, has been widely recognised as a sustainable disinfectant in aquaculture. Earlier reports on PAA underscore its potential to address the challenges of the current AGD treatments. Hence, this project aimed to establish its credentials as a chemotherapeutant for AGD. Stage 1 documented the impacts of PAA exposure on the health and welfare of salmon, its degradation kinetics and its antiparasitic activity against the Paramoeba perurans , the causative agent of AGD. There were 3 in vivo exposure experiments performed where salmon were exposed to varying levels of PAA. Experiment 1 was designed to evaluate whether previous exposure history might desensitise the responses upon re-exposure. Salmon were exposed to different nominal concentrations (0, 0.6, and 2.4 ppm) of PAA for 5 min, followed by a re-exposure to the same concentrations for 30 min 2 weeks later. Experiment 2 explored how a stressful episode before exposure might interfere with the adaptive responses to PAA. Fish were subjected to crowding stress prior to PAA exposure at 4.8 ppm for 30 min. And lastly, Experiment 3 investigated the impacts of repeated exposures to PAA. Salmon were exposed to 10 ppm PAA either for 15 min to 30 min every 3 weeks, with 3 exposures in total. Growth performance was not affected in all exposure trials. Behavioural changes such as agitation, erratic swimming, increased ventilation and loss of balance during exposure were only observed in experiment 3. No significant mortality was recorded in all experiments, and exposed fish recovered quickly after exposure as evidenced by unaffected feeding patterns. Though there were external welfare changes (e.g. skin damage, fin damage) following ... Book Atlantic salmon Technical University of Denmark: DTU Orbit Paa ENVELOPE(-53.483,-53.483,66.017,66.017)
institution Open Polar
collection Technical University of Denmark: DTU Orbit
op_collection_id ftdtupubl
language English
topic Amoebic gill disease
Disinfectant
Gill health
Hydrogen peroxide
Mucosal health
Peracetic acid
spellingShingle Amoebic gill disease
Disinfectant
Gill health
Hydrogen peroxide
Mucosal health
Peracetic acid
Lazado, Carlo Cabacang
Timmerhaus, Gerrit
Pedersen, Lars-Flemming
Pittman, Karin
Soleng, Malene
Haddeland, Sindre
Johansen, Lill-Heidi
Breiland, Mette W
Rørmark, Lisbeth
Mohammed, Saima Nasrin
Hytterød, Sigurd
Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1
topic_facet Amoebic gill disease
Disinfectant
Gill health
Hydrogen peroxide
Mucosal health
Peracetic acid
description Peragill is an initiative that ultimately aims to develop an alternative treatment for the currently available therapies for amoebic gill disease (AGD) that have several practical and environmental issues. Peracetic acid (PAA) is a potent oxidant with a broad spectrum of antimicrobial activity and decays into relatively safe residuals, thus, has been widely recognised as a sustainable disinfectant in aquaculture. Earlier reports on PAA underscore its potential to address the challenges of the current AGD treatments. Hence, this project aimed to establish its credentials as a chemotherapeutant for AGD. Stage 1 documented the impacts of PAA exposure on the health and welfare of salmon, its degradation kinetics and its antiparasitic activity against the Paramoeba perurans , the causative agent of AGD. There were 3 in vivo exposure experiments performed where salmon were exposed to varying levels of PAA. Experiment 1 was designed to evaluate whether previous exposure history might desensitise the responses upon re-exposure. Salmon were exposed to different nominal concentrations (0, 0.6, and 2.4 ppm) of PAA for 5 min, followed by a re-exposure to the same concentrations for 30 min 2 weeks later. Experiment 2 explored how a stressful episode before exposure might interfere with the adaptive responses to PAA. Fish were subjected to crowding stress prior to PAA exposure at 4.8 ppm for 30 min. And lastly, Experiment 3 investigated the impacts of repeated exposures to PAA. Salmon were exposed to 10 ppm PAA either for 15 min to 30 min every 3 weeks, with 3 exposures in total. Growth performance was not affected in all exposure trials. Behavioural changes such as agitation, erratic swimming, increased ventilation and loss of balance during exposure were only observed in experiment 3. No significant mortality was recorded in all experiments, and exposed fish recovered quickly after exposure as evidenced by unaffected feeding patterns. Though there were external welfare changes (e.g. skin damage, fin damage) following ...
format Book
author Lazado, Carlo Cabacang
Timmerhaus, Gerrit
Pedersen, Lars-Flemming
Pittman, Karin
Soleng, Malene
Haddeland, Sindre
Johansen, Lill-Heidi
Breiland, Mette W
Rørmark, Lisbeth
Mohammed, Saima Nasrin
Hytterød, Sigurd
author_facet Lazado, Carlo Cabacang
Timmerhaus, Gerrit
Pedersen, Lars-Flemming
Pittman, Karin
Soleng, Malene
Haddeland, Sindre
Johansen, Lill-Heidi
Breiland, Mette W
Rørmark, Lisbeth
Mohammed, Saima Nasrin
Hytterød, Sigurd
author_sort Lazado, Carlo Cabacang
title Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1
title_short Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1
title_full Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1
title_fullStr Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1
title_full_unstemmed Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1
title_sort peracetic acid as a potential treatment for amoebic gill disease (agd) in atlantic salmon - stage 1
publisher Nofima
publishDate 2019
url https://orbit.dtu.dk/en/publications/8c45ca07-96de-429a-9444-eaedb48feba3
https://backend.orbit.dtu.dk/ws/files/201066543/untitled.pdf
long_lat ENVELOPE(-53.483,-53.483,66.017,66.017)
geographic Paa
geographic_facet Paa
genre Atlantic salmon
genre_facet Atlantic salmon
op_source Lazado , C C , Timmerhaus , G , Pedersen , L-F , Pittman , K , Soleng , M , Haddeland , S , Johansen , L-H , Breiland , M W , Rørmark , L , Mohammed , S N & Hytterød , S 2019 , Peracetic acid as a potential treatment for amoebic gill disease (AGD) in Atlantic salmon - Stage 1 . Nofima Marked. Rapport , no. 21/2019 , Nofima .
op_rights info:eu-repo/semantics/openAccess
_version_ 1766363505302175744